To obtain anal sampling, moisten a Dacron swab with water, not lubricant. Insert the Dacron swab approximately 1.5–2 inches into the anal canal. The swab is rotated 360 degrees with firm lateral pressure applied to the end of the swab. Then place the swab into the SurePath preservative vial and vigorously agitate to disperse the cells. Cut the swab leaving the Dacron tip in the vial.
Label the SurePath vial with patient identification and place in biohazard bag. Submitting personnel must verify source by writing on Cerner label and providing signature.
It is important to use Dacron and not a cotton swab, as cells tend to cling to cotton and do not release easily into cytology collection fluid.
Storage/Transport Temperature
Ambient
Stability (from collection to initiation)
3 weeks
Ordering Recommendations
Persons living with HIV who are less than 30 years of age should be screened annually with a Digital Anal Rectal Exam. Persons living with HIV at age 30 and above should be screened annually with anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam. Persons of any age with a history of cancer of the cervix, vagina, and/or vulva should be screened immediately after diagnosis and then annually. Screening should include anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam. Persons at age 30 and above with a history of high-grade squamous intra-epithelial lesions (HSIL) of the cervix, vagina, and/or vulva should be screened annually with anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam. HIV negative persons at 40 years of age and above and who have regular anoreceptive penetrative sex or anoreceptive play with multiple partners should be screened annually. Screening should include anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam. Persons who are recipients of solid organ transplants should be screened annually starting 2 to 5 years post-transplant. Screening should include anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam.
Performed
Monday - Sunday
Methodology
Cobas PCR
Reported
2 days
Performing Lab
Cytopathology
Synonyms
Anal screen w HPV
Anal pap test
Anal Scrape
Anal pap smear
Anal cytology
8901
Reference Interval
Negative for one or more other High Risk HPV types: 16,18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.
Clinical Interpretation
HPV High Risk type 16, PCR Negative *
HPV High Risk type 18, PCR Negative *
HPV other High Risk Types Negative *
Reference: Negative for one or more other High Risk HPV types: 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.
**** POSITIVE RESULTS ****
HPV High Risk Type 16, PCR
RESULT: **** POSITIVE ****
HPV High Risk Type 18, PCR
RESULT: **** POSITIVE ****
HPV other High Risk Types
RESULT: **** POSITIVE ****
To obtain anal sampling, moisten a Dacron swab with water, not lubricant. Insert the Dacron swab approximately 1.5–2 inches into the anal canal. The swab is rotated 360 degrees with firm lateral pressure applied to the end of the swab. Then place the swab into the SurePath preservative vial and vigorously agitate to disperse the cells. Cut the swab leaving the Dacron tip in the vial.
Label the SurePath vial with patient identification and place in biohazard bag. Submitting personnel must verify source by writing on Cerner label and providing signature.
It is important to use Dacron and not a cotton swab, as cells tend to cling to cotton and do not release easily into cytology collection fluid.
Storage/Transport Temperature
Ambient
Stability (from collection to initiation)
3 weeks
Ordering
Ordering Recommendations
Persons living with HIV who are less than 30 years of age should be screened annually with a Digital Anal Rectal Exam. Persons living with HIV at age 30 and above should be screened annually with anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam. Persons of any age with a history of cancer of the cervix, vagina, and/or vulva should be screened immediately after diagnosis and then annually. Screening should include anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam. Persons at age 30 and above with a history of high-grade squamous intra-epithelial lesions (HSIL) of the cervix, vagina, and/or vulva should be screened annually with anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam. HIV negative persons at 40 years of age and above and who have regular anoreceptive penetrative sex or anoreceptive play with multiple partners should be screened annually. Screening should include anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam. Persons who are recipients of solid organ transplants should be screened annually starting 2 to 5 years post-transplant. Screening should include anal cytology, DNA test for rectal high-risk HPV, and a Digital Anal Rectal Exam.
Performed
Monday - Sunday
Methodology
Cobas PCR
Reported
2 days
Performing Lab
Cytopathology
Synonyms
Anal screen w HPV
Anal pap test
Anal Scrape
Anal pap smear
Anal cytology
8901
Result Interpretation
Reference Interval
Negative for one or more other High Risk HPV types: 16,18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.
Clinical Interpretation
HPV High Risk type 16, PCR Negative *
HPV High Risk type 18, PCR Negative *
HPV other High Risk Types Negative *
Reference: Negative for one or more other High Risk HPV types: 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.
**** POSITIVE RESULTS ****
HPV High Risk Type 16, PCR
RESULT: **** POSITIVE ****
HPV High Risk Type 18, PCR
RESULT: **** POSITIVE ****
HPV other High Risk Types
RESULT: **** POSITIVE ****
